Clinical Trials Sponsored by Instituto de Olhos de Goiania

Total 5523 results

Instituto Nacional de Cancerologia de Mexico

Completed

MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung

Mexico
Instituto de Investigación Marqués de Valdecilla

Unknown

Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) (SARIPET)

Rheumatoid Arthritis | Atherosclerosis
Instituto de Investigación Marqués de Valdecilla

Unknown

Endoscopic Bariatric Therapy in NASH Cirrhosis (ETHIC)

Non-alcoholic Steatohepatitis (NASH)
Instituto de Cardiologia de Santa Catarina

Completed

Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs

Cardiac Catheterisation

Brazil
Instituto de Investigación Marqués de Valdecilla

Completed

Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) (PREVHEP)

Hepatitis B | Hepatitis C

Spain
Instituto Nacional de Cardiologia de Laranjeiras

Completed

The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases

Cardiovascular Diseases

Brazil
Instituto Nacional de Cancerologia de Mexico

Unknown

Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients (SPIROCAN)

Cancer | Critically Ill

Mexico
Instituto Nacional de Cancerologia de Mexico

Completed

Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment

Brain Neoplasms

Mexico
Instituto Nacional de Cancerologia de Mexico

Unknown

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Non-Hodgkin Lymphoma

Mexico
Fundación Instituto de Estudios de Ciencias de...
Instituto de Investigación Biomédica de Salamanca; Grupo Español de Rehabilitación...

Terminated

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

Postoperative Delirium

Spain
Instituto de Investigación Biomédica de Salamanca
Carlos III Health Institute

Recruiting

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Cutaneous T-Cell Lymphoma

Spain
Instituto de Investigación Biomédica de Salamanca
Carlos III Health Institute

Recruiting

Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA) (UMBRELLA-SUMMA)

Myelodysplastic Syndromes

Spain
Institut de Recherches Cliniques de Montreal

Not yet recruiting

Low cArbohydraTe dIeT and aUtomated Insulin Delivery System for Type 1 DiabetEs (LATITUDE)

Type 1 Diabetes
Institut de Recerca Biomèdica de Lleida

Completed

A Nursing Support Intervention-based Project for Stroke Survivors (PROICTUS)

Stroke

Spain
Institut de Recherches Cliniques de Montreal

Completed

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes (REVERSIBLE)

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis (SNACK_CF)

Cystic Fibrosis

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Type 1 Diabetes
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Cancérologie de la Loire

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (VIRAUTO6)

Hematologic Diseases

France
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

Type 1 Diabetes

Canada
Institut de Cancérologie de la Loire

Completed

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Cancer

France
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes (PEP-2)

Obesity | Overweight | Type 2 Diabetes

Canada
Institut de Cancérologie de la Loire

Completed

Screening for Social Weaknesses and Coordination Course of Cancer Patients (DEFCOCANCERO)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation (Nutriprophy)

Prostate Cancer

France
Institut de Recherches Cliniques de Montreal

Terminated

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Hypertension | Type 2 Diabetes | Albuminuria

Canada
Institut de Recherches Cliniques de Montreal

Recruiting

Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training (FEEL-HIIT)

Type 1 Diabetes | Hypoglycemia Unawareness

Canada
Institut de Recherches Cliniques de Montreal

Recruiting

Registry of Patients Living With Type 1 Diabetes

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Completed

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Active, not recruiting

Electrocardiographic Modifications and Spontaneous Hypoglycemic Episodes in Type 1 Diabetes

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Completed

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Effect of Low-Fat Compared to Low-Carbohydrate Diet in Subjects With Multifactorial Chylomicronemia (MCMdiet)

Multifactorial Chylomicronemia (MCM)

Canada
Institut de Recherches Cliniques de Montreal

Completed

Treatment of Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Cancérologie de la Loire

Terminated

Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia (QUALI)

Elderly Patients | Systemic Treatment | Metastatic Neoplasia

France
Institut de Recherches Cliniques de Montreal

Completed

Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control

Type 1 Diabetes

Canada
Institut de Cancérologie de la Loire

Completed

GRAFted Patients' anxieTY Report (GRAFTY)

Autologous Transplant Indication

France
Institut de Recerca Biomèdica de Lleida

Unknown

Adductor Canal Block in an Enhanced Recovery Program After Total Knee Arthroplasty

Knee Osteoarthritis | Total Knee Arthroplasty

Spain
Institut de Recherches Cliniques de Montreal

Completed

Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome (MEDIT)

Metabolic Syndrome | Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients (Kin_YKL_CF)

Cystic Fibrosis

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal

Completed

Insulin-based Strategies to Prevent Hypoglycemia During Exercise

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Terminated

Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea

Type 2 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia

Type 1 Diabetes

Canada
Institut de Cancérologie de la Loire

Unknown

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse (TIPA)

Breast Neoplasms
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Cancérologie de la Loire

Completed

Representations and Prevention of Cancers in Schools (RISCOLAIRE)

Healthy
Institut de Cancérologie de la Loire

Completed

Impact of Media Images, Alcohol and Tobacco to Youth (IMAJE)

Healthy
Institut de Cancérologie de la Loire

Completed

Cancer Fatigue Education Program

Patient With Histologically Confirmed Malignancy

France

3

Subscribe